References
- Levitzki A. Quantitative aspects of ligand binding to receptors. Cellular Receptors for Hormones and Neurotransmitters, D. Schulster, A. Levitzki. John Wiley and Sons, ChichesterUK 1980; 9–28
- Weiland G. A., Molinoff P. B. Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci. 1981; 26: 313–330
- Bennett J. P., Jr., Yamamura H. I. Neurotransmitter, hormone, or drug receptor binding methods. Neurotransmitter Receptor Binding, H. I. Yamamura, S. J. Enna, M. J. Kuhar. Raven Press, New York 1985; 61–89
- Munson P. J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 1980; 107: 220–239
- Duggleby R. G. Regression analysis of nonlinear Arrhenius plots: an empirical model and a computer program. Comp. Biol. Med. 1984; 14: 447–455
- Klotz I. M. Protein interactions with small molecules. Accts. Chem. Res. 1974; 7: 161–168
- Klotz I. M., Hunston D. L. Protein interactions with small molecules. Relationships between stoichiometric binding constants, site binding constants, and empirical binding parameters. J. Biol. Chem. 1975; 250: 3001–3009
- Fletcher J., Spector A. A. Alternative models for the analysis of drug-protein binding. Mol. Pharmacol. 1977; 13: 387–399
- Klotz I. M., Hunston D. L. Protein affinities for small molecules: conceptions and misconceptions. Arch. Biochem. Biophys. 1979; 193: 314–328
- Klotz I. M. Ligand-receptor interactions: facts and fantasies. Quart. Rev. Biophys. 1985; 18: 227–259
- Chang K.-J., Jacobs S., Cuatrecasas P. Quantitative aspects of hormone-receptor interactions of high affinity. Effects of receptor concentration and measurement of dissociation constants of labeled and unlabeled hormones. Biochim. Biophys. Acta 1975; 406: 294–303
- Jacobs S., Chang K.-J., Cuatrecasas P. Estimation of hormone receptor affinity by competitive displacement of labeled ligand: effect of concentration of receptor and of labeled ligand. Biochem. Biophys. Res. Comm. 1975; 61: 687–692
- Linden J. Calculating the dissociation constant of an unlabeled compound from the concentration required to displace radiolabeled binding by 50%. J. Cyclic. Nucleotide Res. 1982; 8: 163–172
- Mooser G., Sigman D. S. Ligand binding properties of acetylcholinesterase determined with fluorescent probes. Biochemistry 1974; 13: 2299–2307
- Clark A. L., Mitchelson F. The inhibitory effect of gallamine on muscarinic receptors. Br. J. Pharmac. 1976; 58: 323–331
- Stockton J. M., Birdsall N. J.M., Burgen A. S.V., Hulme E. C. Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 1983; 23: 551–557
- Ehlert F. J., Roeske W. R., Gee K. W., Yamamura H. I. An allosteric model for benzodiazepine receptor function. Biochem. Pharmacol. 1983; 32: 2375–2383
- Ehlert F. J. “Inverse agonists”, cooperativity and drug action at benzodiazepine receptors. Trends Pharmacol. Sci. 1986; 7: 28–32
- Fletcher J. E., Ashbrook J. D. Computer analysis of drug-protein binding data. Ann. N.Y. Acad. Sci. 1973; 226: 69–81
- Garfinkel L., Kohn M. C., Garfinkel D. Systems analysis in enzyme kinetics. C.R.C. Crit. Rev. Bioenerg. 1977; 2: 329–361
- Munson P. J., Rodbard D. Computerized analysis of ligand binding data: basic principles and recent developments. Computers in Endocrinology, D. Rodbard, G. Forti. Raven Press, New York 1984; 117–145
- Rothman R. B., Barrett R. W., Vaught J. L. Multidimensional analysis of ligand binding data. Neuropeptides 1983; 3: 367–377
- Rothman R. B. Binding surface analysis: an intuitive yet quantitative method for the design and analysis of ligand binding studies. Alcohol and Drug Res. 1986; 6: 309–325